A citation-based method for searching scientific literature

Alberto Puccini, Francesca Battaglin, Maria Laura Iaia, Heinz-Josef Lenz, Mohamed E Salem. J Immunother Cancer 2020
Times Cited: 8







List of co-cited articles
31 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
Dung T Le, Jennifer N Uram, Hao Wang, Bjarne R Bartlett, Holly Kemberling, Aleksandra D Eyring, Andrew D Skora, Brandon S Luber, Nilofer S Azad, Dan Laheru,[...]. N Engl J Med 2015
62

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
25

Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer.
Scott Gettinger, Jungmin Choi, Katherine Hastings, Anna Truini, Ila Datar, Ryan Sowell, Anna Wurtz, Weilai Dong, Guoping Cai, Mary Ann Melnick,[...]. Cancer Discov 2017
260
25

Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study.
Michael J Overman, Ray McDermott, Joseph L Leach, Sara Lonardi, Heinz-Josef Lenz, Michael A Morse, Jayesh Desai, Andrew Hill, Michael Axelson, Rebecca A Moss,[...]. Lancet Oncol 2017
25

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens.
Matthew M Gubin, Xiuli Zhang, Heiko Schuster, Etienne Caron, Jeffrey P Ward, Takuro Noguchi, Yulia Ivanova, Jasreet Hundal, Cora D Arthur, Willem-Jan Krebber,[...]. Nature 2014
25

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma.
Eliezer M Van Allen, Diana Miao, Bastian Schilling, Sachet A Shukla, Christian Blank, Lisa Zimmer, Antje Sucker, Uwe Hillen, Marnix H Geukes Foppen, Simone M Goldinger,[...]. Science 2015
25

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.
Dung T Le, Jennifer N Durham, Kellie N Smith, Hao Wang, Bjarne R Bartlett, Laveet K Aulakh, Steve Lu, Holly Kemberling, Cara Wilt, Brandon S Luber,[...]. Science 2017
25

A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments.
Kevin C Barry, Joy Hsu, Miranda L Broz, Francisco J Cueto, Mikhail Binnewies, Alexis J Combes, Amanda E Nelson, Kimberly Loo, Raj Kumar, Michael D Rosenblum,[...]. Nat Med 2018
341
25

Multilevel genomics of colorectal cancers with microsatellite instability-clinical impact of JAK1 mutations and consensus molecular subtype 1.
Anita Sveen, Bjarne Johannessen, Torstein Tengs, Stine A Danielsen, Ina A Eilertsen, Guro E Lind, Kaja C G Berg, Edward Leithe, Leonardo A Meza-Zepeda, Enric Domingo,[...]. Genome Med 2017
50
25

Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth.
Giovanni Germano, Simona Lamba, Giuseppe Rospo, Ludovic Barault, Alessandro Magrì, Federica Maione, Mariangela Russo, Giovanni Crisafulli, Alice Bartolini, Giulia Lerda,[...]. Nature 2017
252
25

Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis.
Samra Turajlic, Kevin Litchfield, Hang Xu, Rachel Rosenthal, Nicholas McGranahan, James L Reading, Yien Ning S Wong, Andrew Rowan, Nnennaya Kanu, Maise Al Bakir,[...]. Lancet Oncol 2017
415
25

The immunobiology of cancer immunosurveillance and immunoediting.
Gavin P Dunn, Lloyd J Old, Robert D Schreiber. Immunity 2004
25

Resistance to checkpoint blockade therapy through inactivation of antigen presentation.
Moshe Sade-Feldman, Yunxin J Jiao, Jonathan H Chen, Michael S Rooney, Michal Barzily-Rokni, Jean-Pierre Eliane, Stacey L Bjorgaard, Marc R Hammond, Hans Vitzthum, Shauna M Blackmon,[...]. Nat Commun 2017
343
25

Evolving neoantigen profiles in colorectal cancers with DNA repair defects.
Giuseppe Rospo, Annalisa Lorenzato, Nabil Amirouchene-Angelozzi, Alessandro Magrì, Carlotta Cancelliere, Giorgio Corti, Carola Negrino, Vito Amodio, Monica Montone, Alice Bartolini,[...]. Genome Med 2019
16
25

Global proteogenomic analysis of human MHC class I-associated peptides derived from non-canonical reading frames.
Céline M Laumont, Tariq Daouda, Jean-Philippe Laverdure, Éric Bonneil, Olivier Caron-Lizotte, Marie-Pierre Hardy, Diana P Granados, Chantal Durette, Sébastien Lemieux, Pierre Thibault,[...]. Nat Commun 2016
103
25

In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target.
Robert T Manguso, Hans W Pope, Margaret D Zimmer, Flavian D Brown, Kathleen B Yates, Brian C Miller, Natalie B Collins, Kevin Bi, Martin W LaFleur, Vikram R Juneja,[...]. Nature 2017
409
25

Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity.
Stefani Spranger, Riyue Bao, Thomas F Gajewski. Nature 2015
25

Mechanisms of resistance to immune checkpoint inhibitors.
Russell W Jenkins, David A Barbie, Keith T Flaherty. Br J Cancer 2018
467
25

Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4.
Shuang Qin, Linping Xu, Ming Yi, Shengnan Yu, Kongming Wu, Suxia Luo. Mol Cancer 2019
255
25

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.
Jesse M Zaretsky, Angel Garcia-Diaz, Daniel S Shin, Helena Escuin-Ordinas, Willy Hugo, Siwen Hu-Lieskovan, Davis Y Torrejon, Gabriel Abril-Rodriguez, Salemiz Sandoval, Lucas Barthly,[...]. N Engl J Med 2016
25


Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.
Naiyer A Rizvi, Matthew D Hellmann, Alexandra Snyder, Pia Kvistborg, Vladimir Makarov, Jonathan J Havel, William Lee, Jianda Yuan, Phillip Wong, Teresa S Ho,[...]. Science 2015
25

Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial.
Kei Muro, Hyun Cheol Chung, Veena Shankaran, Ravit Geva, Daniel Catenacci, Shilpa Gupta, Joseph Paul Eder, Talia Golan, Dung T Le, Barbara Burtness,[...]. Lancet Oncol 2016
618
25

Advances in immunotherapy for colorectal cancer: a review.
Gol Golshani, Yue Zhang. Therap Adv Gastroenterol 2020
31
25

Cancer treatment and survivorship statistics, 2014.
Carol E DeSantis, Chun Chieh Lin, Angela B Mariotto, Rebecca L Siegel, Kevin D Stein, Joan L Kramer, Rick Alteri, Anthony S Robbins, Ahmedin Jemal. CA Cancer J Clin 2014
25

PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity.
Sydney R Gordon, Roy L Maute, Ben W Dulken, Gregor Hutter, Benson M George, Melissa N McCracken, Rohit Gupta, Jonathan M Tsai, Rahul Sinha, Daniel Corey,[...]. Nature 2017
756
25


International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.
Franck Pagès, Bernhard Mlecnik, Florence Marliot, Gabriela Bindea, Fang-Shu Ou, Carlo Bifulco, Alessandro Lugli, Inti Zlobec, Tilman T Rau, Martin D Berger,[...]. Lancet 2018
778
25


Tumor-Associated Macrophages and Regulatory T Cells Infiltration and the Clinical Outcome in Colorectal Cancer.
Dariusz Waniczek, Zbigniew Lorenc, Mirosław Śnietura, Mariusz Wesecki, Agnieszka Kopec, Małgorzata Muc-Wierzgoń. Arch Immunol Ther Exp (Warsz) 2017
70
25

Immunotherapy in colorectal cancer: rationale, challenges and potential.
Karuna Ganesh, Zsofia K Stadler, Andrea Cercek, Robin B Mendelsohn, Jinru Shia, Neil H Segal, Luis A Diaz. Nat Rev Gastroenterol Hepatol 2019
303
25

Translesion DNA Synthesis across the heptanone--etheno-2'-deoxycytidine adduct in cells.
Michael Pollack, In-Young Yang, Hye-Young H Kim, Ian A Blair, Masaaki Moriya. Chem Res Toxicol 2006
36
12

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.
Robert S Sandler, Susan Halabi, John A Baron, Susan Budinger, Electra Paskett, Roger Keresztes, Nicholas Petrelli, J Marc Pipas, Daniel D Karp, Charles L Loprinzi,[...]. N Engl J Med 2003
847
12

Evolving synergistic combinations of targeted immunotherapies to combat cancer.
Ignacio Melero, David M Berman, M Angela Aznar, Alan J Korman, José Luis Pérez Gracia, John Haanen. Nat Rev Cancer 2015
416
12


Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities.
Douglas R Morgan, Javier Torres, Rachael Sexton, Rolando Herrero, Eduardo Salazar-Martínez, E Robert Greenberg, Luis Eduardo Bravo, Ricardo L Dominguez, Catterina Ferreccio, Eduardo C Lazcano-Ponce,[...]. JAMA 2013
53
12

Ornithine Decarboxylase in Macrophages Exacerbates Colitis and Promotes Colitis-Associated Colon Carcinogenesis by Impairing M1 Immune Responses.
Kshipra Singh, Lori A Coburn, Mohammad Asim, Daniel P Barry, Margaret M Allaman, Chanjuan Shi, M Kay Washington, Paula B Luis, Claus Schneider, Alberto G Delgado,[...]. Cancer Res 2018
29
12

Free radical lipid peroxidation: mechanisms and analysis.
Huiyong Yin, Libin Xu, Ned A Porter. Chem Rev 2011
677
12

Ornithine decarboxylase regulates M1 macrophage activation and mucosal inflammation via histone modifications.
Dana M Hardbower, Mohammad Asim, Paula B Luis, Kshipra Singh, Daniel P Barry, Chunying Yang, Meredith A Steeves, John L Cleveland, Claus Schneider, M Blanca Piazuelo,[...]. Proc Natl Acad Sci U S A 2017
80
12

Spermine oxidase mediates Helicobacter pylori-induced gastric inflammation, DNA damage, and carcinogenic signaling.
Johanna C Sierra, M Blanca Piazuelo, Paula B Luis, Daniel P Barry, Margaret M Allaman, Mohammad Asim, Thomas A Sebrell, Jordan L Finley, Kristie L Rose, Salisha Hill,[...]. Oncogene 2020
11
12

Increased Helicobacter pylori-associated gastric cancer risk in the Andean region of Colombia is mediated by spermine oxidase.
R Chaturvedi, T de Sablet, M Asim, M B Piazuelo, D P Barry, T G Verriere, J C Sierra, D M Hardbower, A G Delgado, B G Schneider,[...]. Oncogene 2015
51
12

Accumulation of somatic mutations in TP53 in gastric epithelium with Helicobacter pylori infection.
Takahiro Shimizu, Hiroyuki Marusawa, Yuko Matsumoto, Tadashi Inuzuka, Atsuyuki Ikeda, Yosuke Fujii, Sachiko Minamiguchi, Shin'ichi Miyamoto, Tadayuki Kou, Yoshiharu Sakai,[...]. Gastroenterology 2014
85
12

An Approach to Breast Cancer Diagnosis via PET Imaging of Microcalcifications Using (18)F-NaF.
George H Wilson, John C Gore, Thomas E Yankeelov, Stephanie Barnes, Todd E Peterson, Jarrod M True, Sepideh Shokouhi, J Oliver McIntyre, Melinda Sanders, Vandana Abramson,[...]. J Nucl Med 2014
17
12

NADPH oxidase 1 supports proliferation of colon cancer cells by modulating reactive oxygen species-dependent signal transduction.
Agnes Juhasz, Susan Markel, Shikha Gaur, Han Liu, Jiamo Lu, Guojian Jiang, Xiwei Wu, Smitha Antony, Yongzhong Wu, Giovanni Melillo,[...]. J Biol Chem 2017
40
12

DC isoketal-modified proteins activate T cells and promote hypertension.
Annet Kirabo, Vanessa Fontana, Ana P C de Faria, Roxana Loperena, Cristi L Galindo, Jing Wu, Alfiya T Bikineyeva, Sergey Dikalov, Liang Xiao, Wei Chen,[...]. J Clin Invest 2014
262
12

Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab.
Suzanne L Topalian, Mario Sznol, David F McDermott, Harriet M Kluger, Richard D Carvajal, William H Sharfman, Julie R Brahmer, Donald P Lawrence, Michael B Atkins, John D Powderly,[...]. J Clin Oncol 2014
12

Mechanisms of disease: chronic inflammation and cancer in the pancreas--a potential role for pancreatic stellate cells?
Hana Algül, Matthias Treiber, Marina Lesina, Roland M Schmid. Nat Clin Pract Gastroenterol Hepatol 2007
78
12

Global patterns and trends in colorectal cancer incidence and mortality.
Melina Arnold, Mónica S Sierra, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. Gut 2017
12

Prostaglandin H2 (PGH2) accelerates formation of amyloid beta1-42 oligomers.
Olivier Boutaud, Joyce J Ou, Pierre Chaurand, Richard M Caprioli, Thomas J Montine, John A Oates. J Neurochem 2002
49
12

Levuglandin forms adducts with histone h4 in a cyclooxygenase-2-dependent manner, altering its interaction with DNA.
Erica J Carrier, Irene Zagol-Ikapitte, Venkataraman Amarnath, Olivier Boutaud, John A Oates. Biochemistry 2014
20
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.